Join our community of smart investors

Transformation heralds sweeter future for Tate & Lyle

This food ingredients business is restructuring, with a major sale due to complete by the end of March
February 24, 2022

Thoughts of Tate & Lyle (TATE) are likely to conjure up images of golden syrup or, for the connoisseur who enjoys a more bitter-sweet dessert, black treacle.

Tip style
Growth
Risk rating
Medium
Timescale
Medium Term
Bull points
  • Strategic transformation on track
  • Inflation offset by pricing contracts
  • £500mn special dividend expected
Bear points
  • Reliant on health trends
  • Lower earnings base

It’s now been over a decade since the group sold its sugar refining operations for more than £200mn, with the lingering association demonstrating the power of branding and good products, as the business moved to a focus on food and bulk ingredients.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in